Materials & Resources » Chemicals | Eckert & Ziegler Strahlen- und Medizintechnik AG

Eckert & Ziegler Strahlen- und Medizintechnik AG | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
117,138.00
127,256.00
139,747.00
119,868.00
138,631.00
168,709
Cost of Goods Sold (COGS) incl. D&A
63,937.00
67,129.00
81,201.00
64,080.00
78,899.00
97,891
Gross Income
53,201.00
60,127.00
58,546.00
55,788.00
59,732.00
70,818
SG&A Expense
45,109.00
48,759.00
51,473.00
42,340.00
43,285.00
50,404
EBIT
-
11,368.00
-
-
17,123.00
20,414
Unusual Expense
931.00
-
883.00
8.00
1,075.00
970
Non Operating Income/Expense
5,445.00
1,847.00
12,047.00
2,681.00
226.00
1,954
Interest Expense
772.00
1,278.00
1,442.00
1,163.00
881.00
672
Pretax Income
12,454.00
12,405.00
17,347.00
15,419.00
17,343.00
22,837
Income Tax
1,824.00
5,299.00
5,626.00
4,971.00
5,320.00
5,997
Equity in Affiliates
183.00
609.00
408.00
-
-
49
Consolidated Net Income
10,447.00
6,497.00
11,313.00
10,448.00
12,023.00
16,889
Net Income
9,035.00
6,775.00
11,665.00
10,212.00
11,602.00
16,133
Net Income After Extraordinaries
9,035.00
6,775.00
12,612.00
10,874.00
8,503.00
16,133
Net Income Available to Common
9,035.00
6,775.00
10,718.00
9,550.00
14,701.00
16,133
EPS (Basic)
1.71
1.28
2.03
1.81
2.78
3.12
Basic Shares Outstanding
5,288.00
5,288.00
5,288.00
5,288.00
5,288.00
5,168
EPS (Diluted)
1.71
1.28
2.03
1.81
2.78
3.12
Diluted Shares Outstanding
5,288.00
5,288.00
5,288.00
5,288.00
5,288.00
5,168
EBITDA
14,392.00
18,511.00
15,631.00
20,545.00
25,396.00
28,858
Other Operating Expense
694.00
-
387.00
-
676.00
-
Non-Operating Interest Income
1,314.00
468.00
165.00
445.00
252.00
171
Minority Interest Expense
1,412.00
278.00
352.00
236.00
421.00
756

About Eckert & Ziegler Strahlen- und Medizintechnik

View Profile
Address
Robert-Rössle-Strasse 10
Berlin Berlin 13125
Germany
Employees -
Website http://www.ezag.de
Updated 07/08/2019
Eckert & Ziegler Strahlen- und Medizintechnik AG is a provider of isotope technology for medical, scientific, and industrial use. It operates through the following segments: Radiation Therapy, Isotope Products, Radiopharma, and Holding. The Radiation Therapy segment concentrates on product development, manufacturing, the market introduction, and the sale of radioactive products for cancer therapy.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.